课题基金 / 基金详情

The quantification of ratios between apo to holo types of metal binding protein : a new indicator of the oxidative stress in cells

The quantification of ratios between apo to holo types of metal binding protein : a new indicator of the oxidative stress in cells
金属结合蛋白apo与holo类型之间比率的定量:细胞氧化应激的新指标
批准号:
11672314
负责人:
NAKANISHI Toyofumi
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2001

项目摘要

项目成果

NAKANISHI Toyofumi的其他基金

相关文献

中文摘要
翻译
我们应用纳米电喷雾电离质谱法(NanoESIMS)对载子型和全型金属蛋白(铜/锌结合超氧化物歧化酶:SOD-1、金属硫氨酸)进行定量分析,以阐明家族性肌萎缩性侧索硬化症等神经退行性疾病的病因。采用金属蛋白标准品和纯化金属蛋白,研究了超灵敏质谱法定量测定金属蛋白含量的最佳条件。1)考察了样品溶液的pH范围、有机溶剂的含量、加热毛细管的温度等条件。2)采用电感耦合等离子体质谱(ICPMS)代替纳米esims技术。采用商用SOD-1标准品,修改了分析条件,仍不能检测到二聚体、全息型。我们放弃了纳米esims技术最优条件的构建。另一方面,我们应用了ICPMS技术或SOD-1的全型转化,成功实现了金属蛋白的全型。该技术(ICPMS)是定量测定载脂蛋白与全型金属蛋白比率的有力工具。
英文摘要
We applied nano-electrospray ionization mass spectrometry (NanoESIMS) for the quantification of the rations between apo to holo types of metalloproteins (copper/zinc binding superoxide dismutase:SOD-1, metallothioneine) to clarify the etiology of neurodegenerative diseases such as familial amyotrophic lateral sclerosis. We examined the optimal conditions of ultra-sensitive mass spectrometric quantification of the ratios using metalloproteins standard and purified metalloproteins.1) We examined the condition of pH range of sample solutions, contents of organic solvent and temperature of heated capillary.2) We applied inductively coupled plasma mass spectrometry (ICPMS) instead of nanoESIMS technique.Using the commercial SOD-1 standard, we could not detect dimer, holo type even though we modified some analytical conditions. We give up the construction of the optimal condition of NanoESIMS technique. On the other hand, we applied the ICPMS technique or the de e turn of holo type of SOD-1 and succeeded holo type of the metalloprotem. This technique (ICPMS) was a powerful tool of the quantification of the ratios between apo to holo types of metalloproteins.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
Miyazaki A,Nakanishi T,Kishikawa M,Nakagawa T,Shimizu A,Mawjood AHM,Imai K,Aoki Y & Kikuchi M.: "Compound heterozygosity for b+-thalassemia-31(A->G)and a variant with low oxygan affinity,Hb Sagami[b139(H17)Asn->Thr]"Hemoglobin.. 23・3. 267-271 (1999)
Miyazaki A、Nakanishi T、Kishikawa M、Nakakawa T、Shimizu A、Mawjood AHM、Imai K、Aoki Y 和 Kikuchi M.:“b+-地中海贫血-31(A->G)的复合杂合性和低氧亲和力的变体,Hb 相模[b139(H17)Asn->Thr]“血红蛋白.. 23・3. 267-271 (1999)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kishikawa M,Nakanishi T,Miyazaki A & Shimizu A.: "Enhanced amyloidogenicity of sulfonated transthyretin in vitro,a hypothetical etiology of senile"Amyloid: Int J Exp Clin Invest. 6・3. 183-186 (1999)
Kishikawa M、Nakanishi T、Miyazaki A 和 Shimizu A.:“磺化转甲状腺素蛋白的体外淀粉样变性增强,老年的假设病因”淀粉样蛋白:Int J Exp Clin Invest 6·3(1999)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
T. Hiratsuka, M. Nakazato, T. Minematsu, N. Chiono, T. Nakanishi, A. Shimizu, M. Nakazato, S. Matsukura: "Structural analysis of human β-defensine-1 and its significance in urinary tract infection"Nephron. 85 (1). 34-40 (2000)
T. Hiratsuka、M. Nakazato、T. Minematsu、N. Chiono、T. Nakanishi、A. Shimizu、M. Nakazato、S. Matsukura:“人 β-defensine-1 的结构分析及其在尿路感染中的意义”肾单位。85(1)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
A. Shimizu, T. Nakanishi, M. Kishikawa, A. Miyazaki: "Detection and identification of protein variants and adducts in blood and tissues: an application of soft ionization mass spectrometry to clinical diagnosis"J. Chromatography B. (in press).
A. Shimizu、T. Nakanishi、M. Kishikawa、A. Miyazaki:“血液和组织中蛋白质变异体和加合物的检测和鉴定:软电离质谱在临床诊断中的应用”J。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 11 条
    Investigation of the molecular mechanism of the radical reaction to induce the amyloid fibril derived from the transthyretin
    • 批准号:
      22590540
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2010
    • 负责人:
      NAKANISHI Toyofumi
    • 依托单位:
    Identifications of non-Hodgkin's lymphoma (NHL)-specific antigens bounded with autoantibodies in plasma derived from patients with NHL by an autoantibodiomics
    • 批准号:
      19590574
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2007
    • 负责人:
      NAKANISHI Toyofumi
    • 依托单位:
    Identifications of diagnostic biomarkers specific binding to soluble proteins of adenocarcinoma A 549 cell lines by an autoantibodiomics
    • 批准号:
      17590501
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.3万
    • 财政年份:
      2005
    • 负责人:
      NAKANISHI Toyofumi
    • 依托单位:
    Expression proteomics of angiogenesis-modulated factors in human vitreous humors derived from diabetic retinopathy
    • 批准号:
      14572190
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2002
    • 负责人:
      NAKANISHI Toyofumi
    • 依托单位: